glp/gip/glucagon & cagrilintide 8mg/2mg Is retatrutide better than tirzepatide? Triple vs dual agonist compared Targeting GLP-1, GIP & GCG

Targeting GLP 1, GIP & GCG in Obesity and Type 2 Diabetes Research Cagrilintide (2.5mg) GLP 1 S (2.5mg) LGI peptides In a phase 3 trial of Chinese adults with #obesity, mazdutide produced a sustained and clinically meaningful reduction in body #weight over 60 weeks, with additional improvements in waist circumference and #cardiometabolic Eli Lilly's Phase 3 clinical studies investigating retatrutide, the "triple G" agonist, have found that long term use can achieve substantial weight loss. Read about the work via the link in the comments.

SKU: 36769489863 · From www.paramparam.eu